NSE - Delayed Quote INR
Bafna Pharmaceuticals Limited (BAFNAPH.NS)
80.40
+3.48
+(4.52%)
At close: April 25 at 3:13:46 PM GMT+5:30
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
1,476,816
1,295,832
901,446
864,659
Total Liabilities Net Minority Interest
668,429
561,286
281,809
296,948
Total Equity Gross Minority Interest
808,387
734,546
619,637
567,711
Total Capitalization
915,919
818,879
672,807
592,711
Common Stock Equity
808,387
734,546
619,637
567,711
Net Tangible Assets
790,687
719,546
619,637
567,711
Working Capital
403,869
408,354
288,671
253,594
Invested Capital
1,052,280
963,785
730,231
697,711
Tangible Book Value
790,687
719,546
619,637
567,711
Total Debt
243,893
229,239
110,594
130,000
Net Debt
229,933
151,145
110,400
122,524
Share Issued
23,656.34
23,656.34
23,656.34
23,656.34
Ordinary Shares Number
23,656.34
23,656.34
23,656.34
23,656.34
3/31/2021 - 11/12/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade